ERYTECH receives the EnterNext Tech 40 Label Post author:admERY Post published:April 28, 2015 Post category:Newsroom ERYTECH has received the EnterNext Tech 40 Label and announces its inclusion in the Tech 40 index. You Might Also Like ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021 September 20, 2021 ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases February 8, 2022 ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States May 13, 2019
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021 September 20, 2021
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States May 13, 2019
